SUNNYVALE, Calif., Feb. 7, 2023
/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced
today its participation in the virtual BTIG MedTech, Digital
Health, Life Science & Diagnostic Tools Conference, which takes
place February 14-16, 2023.
BTIG-hosted events are intended for prospective and existing
BTIG clients only. To request a one-on-one meeting with management
or to listen to the live event, please contact your BTIG
representative with interest.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to
expanding the powerful potential of radiation therapy to improve as
many lives as possible. We invent unique, market-changing solutions
that are designed to deliver radiation treatments for even the most
complex cases—while making commonly treatable cases even easier—to
meet the full spectrum of patient needs. We are dedicated to
continuous innovation in radiation therapy for oncology,
neuro-radiosurgery, and beyond, as we partner with clinicians and
administrators, empowering them to help patients get back to their
lives, faster. Accuray is headquartered
in Sunnyvale, California,
with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn,
Twitter, and YouTube.
Investor Contact
Aman Patel, CFA
ICR Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-in-the-btig-medtech-digital-health-life-science--diagnostic-tools-conference-301740458.html
SOURCE Accuray Incorporated